Article

NME4 promotes cell malignant process by targeting SMAD2 in colorectal cancer

2023-05-04

Abstract excerpt

Nucleoside diphosphate kinase 4 (NME4) is aberrantly expressed in several cancer types. However, the function of NME4 in colorectal cancer (CRC) remains to be elucidated. Bioinformatic analysis and clinical sample collection revealed that NME4 was highly expressed in CRC tissues and positively correlated with stage and tumor size. Knockdown of NME4 expression inhibited the proliferation and migration of CRC cells...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 88d48201-0413-527c-99a8-63541d48b2bb
DOI: 10.21203/rs.3.rs-2876848/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

NME4 promotes cell malignant process by targeting SMAD2 in colorectal cancerDOI 10.21203/rs.3.rs-2876848/v1Read

NOTCH4 regulates colorectal cancer proliferation, invasiveness, and determines clinical outcome of patientsSemantic proximity Read

Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.Semantic proximity Read

Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysisSemantic proximity Read

Correlation Between SMADs and Colorectal Cancer Expression, Prognosis, and Immune InfiltratesSemantic proximity Read

MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway.Semantic proximity Read

RNF114 facilitates the proliferation, stemness, and metastasis of colorectal cancerSemantic proximity Read

An Update on the Potential Roles of E2F Family Members in Colorectal CancerSemantic proximity Read

CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signalingSemantic proximity Read

CRNDE : An important oncogenic long non‐coding RNA in human cancersSemantic proximity Read

MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathwaySemantic proximity Read

Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathwaySemantic proximity Read

Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transitionSemantic proximity Read